Login
$ZBIO
$27.24 +$0.37 (1.38%) Close

Company Executives

$ZBIO Management Team

Mr. Leon Moulder

Founder

Chairman of the Board of Director

Chief Executive Officer

Age 67
Compensation $20.00M USD
Sex Male

Mr. Joseph Farmer

President

Chief Operating Officer

Age 53
Compensation $6.004M USD
Sex Male

Mr. Orlando Oliveira

Chief Commercial Officer

Age 49
Compensation $5.891M USD
Sex Male

Dr. Haley Laken

Chief Scientific Officer

Age -
Compensation -
Sex Female

Dr. Lisa von Moltke

Head of Research and Development

Chief Medical Officer

Age 66
Compensation -
Sex Female

Ms. Jennifer Fox

Chief Business Officer

Chief Financial Officer

Age 53
Compensation $4.735M USD
Sex Female
Directors
8
serving now
Independent
Not stated
the proxy does not say
Average tenure
4.0 years
from year joined
CEO also chairs the board
Yes
Leon O. Moulder, Jr.
Director Age On board Independent Committees Other public boards 2025 pay Source
Leon O. Moulder, Jr.
68 2020
6 years
Not stated None stated Zai Lab Ltd. Paid as CEO
Hongbo Lu
55 2022
4 years
Not stated
Nominating Committee Science Committee
Arrowhead Pharmaceuticals Not stated
James Boylan
58 2022
4 years
Not stated
Audit Committee Compensation Committee
Immunome Therapeutics Inc. $241,873
Patrick Enright
64 2022
4 years
Not stated
Audit Committee Compensation Committee
Veradermics, Incorporated, Vera Therapeutics, Inc. $225,023
Tomas Kiselak Leaving at the meeting
39 2020
6 years
Not stated
Nominating Committee Science Committee
Viridian Therapeutics, Inc. $216,949
Patricia Allen
64 2024
2 years
Not stated
Audit Committee · Chair
None stated $229,023
Jake Nunn
55 2024
2 years
Not stated
Nominating and Corporate Governance Committee · Chair
Addex Therapeutics Ltd. $219,023
John Orloff
68 2022
4 years
Not stated
Compensation Committee · Chair Science and Technology Committee · Chair
None stated $226,875

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Mar 16, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support